Related Experiment Video
Updated: May 6, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei
Zheng Zhang1, Sriram Jakkaraju, Joy Blain
1Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL, USA.
Abstract:
Published biological data suggest that the methyl erythritol phosphate (MEP) pathway, a non-mevalonate isoprenoid biosynthetic pathway, is essential for certain bacteria and other infectious disease organisms. One highly conserved enzyme in the MEP pathway is 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase (IspF). Fragment-bound complexes of IspF from Burkholderia pseudomallei were used to design and synthesize a series of molecules linking the cytidine moiety to different zinc pocket fragment binders. Testing by surface plasmon resonance (SPR) found one molecule in the series to possess binding affinity equal to that of cytidine diphosphate, despite lacking any metal-coordinating phosphate groups. Close inspection of the SPR data suggest different binding stoichiometries between IspF and test compounds. Crystallographic analysis shows important variations between the binding mode of one synthesized compound and the pose of the bound fragment from which it was designed. The binding modes of these molecules add to our structural knowledge base for IspF and suggest future refinements in this compound series.
Insights
Researchers designed novel molecules targeting the essential bacterial enzyme 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase (IspF). One compound showed high binding affinity, offering new strategies for infectious disease treatments.
Area of Science:
- Microbiology
- Biochemistry
- Medicinal Chemistry
Background:
- The methyl erythritol phosphate (MEP) pathway is crucial for isoprenoid biosynthesis in many bacteria and pathogens.
- 2C-methyl-d-erythritol 2,4-cyclodiphosphate synthase (IspF) is a highly conserved and essential enzyme within the MEP pathway.
- Targeting essential bacterial pathways like MEP offers a promising strategy for developing new anti-infective agents.
Purpose of the Study:
- To design and synthesize novel inhibitors targeting the IspF enzyme.
- To investigate the binding interactions of these compounds with IspF using biophysical and crystallographic methods.
- To explore the potential of these compounds as leads for new anti-infective drug development.
Main Methods:
- Structure-based drug design utilizing fragment-bound complexes of Burkholderia pseudomallei IspF.
- Synthesis of a molecular series linking a cytidine moiety to various zinc pocket binders.
- Surface plasmon resonance (SPR) for assessing binding affinity and kinetics.
- X-ray crystallography for detailed structural analysis of compound-enzyme interactions.
Main Results:
- A synthesized molecule demonstrated binding affinity comparable to cytidine diphosphate, a natural substrate, without metal-coordinating phosphate groups.
- SPR analysis indicated potential differences in binding stoichiometry between IspF and the tested compounds.
- Crystallographic data revealed significant variations in the binding mode of a synthesized compound compared to its design template.
- The study provides new structural insights into IspF-inhibitor interactions.
Conclusions:
- Novel IspF inhibitors with high binding affinity have been developed, offering a new avenue for targeting the MEP pathway.
- The structural and binding data provide a foundation for further optimization of this compound series.
- These findings contribute to the development of potential therapeutics against bacterial infections by inhibiting essential metabolic pathways.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Inhibition of Cdk Activity
Inhibitors of Viral Protein Synthesis

